Drug intelligence / Profile preview

paracetamol + opium powder + caffeine

Development stage
Phase 3
Lead developer
Sanofi
Modality
Small Molecules
Administration
Oral
01

Overview

paracetamol + opium powder + caffeine is a fixed-dose combination analgesic used for the treatment of moderate pain. It contains three active ingredients: paracetamol (acetaminophen), which acts as an antipyretic and analgesic by inhibiting hypothalamic heat-regulating centers and cyclooxygenase enzymes in the CNS; opium powder (opium prepared), which supplies several opioid alkaloids acting as agonists primarily at the mu-opioid receptor to block transmission of pain signals; and caffeine, a central nervous system stimulant that enhances analgesic efficacy, likely through increased absorption and pharmacodynamic synergy. This combination is primarily indicated for the management of moderate pain, including dental pain and postoperative pain, and has rapid onset of action. Its efficacy has been established as non-inferior and, in certain cases, superior to tramadol in acute postoperative pain[2][3].

Brand names
lamaline
Other names
paracetamol + opium prepared + caffeineacetaminophen + opium + caffeine
02

Targets

COXADOR (Adenosine receptors)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on paracetamol + opium powder + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + opium powder + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call